將 VitaStem VITASTEM 轉換為 DIMO DIMO

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

DIMO is the utility token powering the future machine economy. Starting with connected vehicles, the DIMO protocol creates blockchain-based identities for cars, drivers, apps, and sensors, enabling them to interact, transact, and coordinate autonomously. Vehicle owners earn DIMO tokens by sharing their data, while the token also governs this emerging protocol for machine-to-machine interactions. Built with open-source components on the Ethereum Virtual Machine, DIMO aims to increase transparency, privacy, and reliability in IoT networks, thereby fostering trust among users and developers. DIMO can expand beyond cars to robotics, energy, and other IoT categories in the future.